Abstract | PURPOSE: DESIGN: This is a clinically interventional case series study. METHODS: RESULTS: The study consisted of 36 patients (38 eyes) with a mean (SD) age of 77.9 (7.4) years. The mean (SD) visual acuity before the injection of bevacizumab was 0.84 (0.46) logMAR. After a mean (SD) follow-up of 10.1 (5.8) months (range, 2-21.9 months), the mean visual acuity was 0.94 (0.47) logMAR, without a statistically significant difference between the baseline value and the posttreatment value (P = 0.06; 95% confidence interval for the difference, -0.22 to 0.01 logMAR). CONCLUSIONS:
|
Authors | Jost B Jonas, Teodosio Libondi, Lidia Golubkina |
Journal | Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
(Asia Pac J Ophthalmol (Phila))
2012 May-Jun
Vol. 1
Issue 3
Pg. 140-1
ISSN: 2162-0989 [Print] China |
PMID | 26107329
(Publication Type: Journal Article)
|